These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 22409455)
21. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists. Ashkenazi A Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Imam JS; Buddavarapu K; Lee-Chang JS; Ganapathy S; Camosy C; Chen Y; Rao MK Oncogene; 2010 Sep; 29(35):4971-9. PubMed ID: 20603620 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-mediated posttranscriptional mechanisms of gene expression in proliferating and quiescent cancer cells. Letonqueze O; Lee J; Vasudevan S RNA Biol; 2012 Jun; 9(6):871-80. PubMed ID: 22699554 [TBL] [Abstract][Full Text] [Related]
24. Apoptosis and non-apoptotic deaths in cancer development and treatment response. de Bruin EC; Medema JP Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718 [TBL] [Abstract][Full Text] [Related]
25. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Santarpia L; Nicoloso M; Calin GA Endocr Relat Cancer; 2010 Mar; 17(1):F51-75. PubMed ID: 19843580 [TBL] [Abstract][Full Text] [Related]
26. The role of microRNAs in cancer: no small matter. Wiemer EA Eur J Cancer; 2007 Jul; 43(10):1529-44. PubMed ID: 17531469 [TBL] [Abstract][Full Text] [Related]
27. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer]. Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841 [TBL] [Abstract][Full Text] [Related]
29. The miR-34 family in cancer and apoptosis. Hermeking H Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653 [TBL] [Abstract][Full Text] [Related]
30. The role of microRNAs in normal and malignant hematopoiesis. Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129 [TBL] [Abstract][Full Text] [Related]
31. New role of microRNA: carcinogenesis and clinical application in cancer. Zhao L; Chen X; Cao Y Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):831-9. PubMed ID: 21908856 [TBL] [Abstract][Full Text] [Related]
32. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Tsang WP; Kwok TT Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960 [TBL] [Abstract][Full Text] [Related]
33. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Babashah S; Soleimani M Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473 [TBL] [Abstract][Full Text] [Related]
34. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death. Andreoli V; Gehrau RC; Bocco JL IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818 [TBL] [Abstract][Full Text] [Related]
35. p53 and response to chemotherapy and radiotherapy. Ruley HE Important Adv Oncol; 1996; ():37-56. PubMed ID: 8791127 [No Abstract] [Full Text] [Related]
36. Casein Kinase II: an attractive target for anti-cancer drug design. Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317 [TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in apoptosis, autophagy and necroptosis. Su Z; Yang Z; Xu Y; Chen Y; Yu Q Oncotarget; 2015 Apr; 6(11):8474-90. PubMed ID: 25893379 [TBL] [Abstract][Full Text] [Related]
38. [Relation of micro-RNA and carcinogenesis]. Fan B; Zhang L; Ma C Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):401-4. PubMed ID: 22967438 [No Abstract] [Full Text] [Related]